U.S. AI Laws and Why They Matter in U.S. Healthcare

AI models processing protected health information without proper authorization can lead to compliance issues. Treat AI as a governed clinical support tool rather than an unmanaged shortcut. This practice can protect both patient trust and professional responsibility. Conversational AI can also make care access feel easier for patients. But, these benefits only hold if privacy, security, and clinical oversight, and applicable laws are built into the workflow from the start. The goal is not to shy away from AI, but to seamlessly integrate it with clearly defined boundaries, documented controls, and a workflow that puts legal compliance at the forefront.

Artificial intelligence can responsibly assist healthcare professionals in several ways, including: Drafting patient portal replies, Summarizing records, Creating after-visit instructions, Supporting triage workflows, Transcribing visits with controls, Answering scheduling or billing questions, Identifying documentation gaps. Conversational AI adds another layer because it interacts directly with patients or staff through chat, voice, or text. Data retention by AI and Technology providers for system improvements, is another area requiring careful scrutiny, ensuring patient data is used and reused lawfully with necessary permissions and safeguards.

Laws Governing Healthcare-AI in the U.S.

The United States has no single comprehensive healthcare-AI privacy law. Requirements are divided among federal sector-specific laws, medical-device regulation, consumer-protection rules, state-by-state privacy laws, and professional or contractual standards.

Teams deploying Ai should create a plan which connects each control to a law or legal policy requirement.

A practical US compliance review should therefore assess four separate questions:

• Privacy: Is the data PHI, consumer health data, biometric data, genetic data, student data, or research data?

• Jurisdiction: Which federal and state laws apply based on the provider, vendor, patient, and location of care?

• Clinical regulation: Does the AI make, support, or influence a medical decision, or qualify as a medical device?

• Governance/Compliance: Are validation, human oversight, bias testing, security, patient notice, audit logs, vendor controls, and incident response documented?

  
  

The most important point is that PHI is not a law. HIPAA regulates PHI only when it is handled by covered entities or business associates; consumer health apps, data brokers, employers, schools, and AI companies may instead be governed by the FTC, state privacy laws, biometric or genetic laws, or other industry-specific rules. The US framework is a patchwork of federal and state requirements rather than one nationwide AI-healthcare statute.

The following table summarizes key laws and policies that commonly apply to Artificial Intelligence in U.S. healthcare :

Law or policy	Why it matters in healthcare - AI
HIPAA Privacy Rule — United States	Governs the use and disclosure of protected health information (PHI) by healthcare providers, health plans, healthcare clearinghouses, and their vendors. AI systems using PHI need an authorized purpose, appropriate contracts, minimum-necessary access, patient-rights processes, auditability, and controls over model training, prompts, outputs, logs, and vendor reuse.
HIPAA Security Rule — United States; applies to covered entities and business associates handling electronic PHI	Requires administrative, physical, and technical safeguards. AI deployments should address access control, authentication, encryption where appropriate, risk analysis, backups, logging, vulnerability management, model and data isolation, and incident response.
HIPAA Breach Notification Rule — United States; applies to covered entities and business associates	Requires notification after certain breaches of unsecured PHI. Organizations should determine whether an AI vendor incident, exposed training set, compromised prompt history, or unauthorized model output constitutes a reportable breach.
Americans with Disabilities Act and Section 1557 of the Affordable Care Act — United States	AI used for triage, scheduling, benefits, utilization review, recruitment, or clinical decisions must not unlawfully discriminate against people with disabilities or protected groups. Accessibility, accommodation, bias testing, and human escalation are important controls.
PHI (Patient Health Information) — United States; a HIPAA-defined category, not a separate law	PHI is individually identifiable health information held or transmitted by a covered entity or business associate. AI data may remain PHI in training datasets, retrieval systems, prompts, generated summaries, logs, and outputs. Proper HIPAA de-identification can remove data from the PHI definition, but other laws may still apply.
HITECH Act — United States	Strengthens security, breach notification, enforcement, patient access, and vendor-accountability requirements. It is relevant to AI procurement, security assessments, data sharing, electronic records, and oversight of technology suppliers.
42 CFR Part 2 — United States	Provides heightened confidentiality protection for substance-use-disorder records. AI tools processing these records require specialized consent, disclosure, access, and segregation controls in addition to ordinary HIPAA controls. The 2024 final rule aligned some Part 2 requirements with HIPAA and HITECH while preserving special protections. Department of Health & Human Services
21st Century Cures Act and ONC Information Blocking Rule — United States	Restricts unjustified interference with access to or exchange of electronic health information. AI-generated records, decision-support data, and information stored in AI-enabled EHR tools must not be used to improperly obstruct patient or provider access.
Federal Food, Drug, and Cosmetic Act and FDA medical-device regulations — United States	Diagnostic, imaging, monitoring, clinical-decision, and treatment software may require FDA authorization, clinical evidence, quality systems, labeling, cybersecurity, and post-market monitoring. Adaptive or updated models need documented change-control and performance-monitoring processes.
Federal Trade Commission Act — United States	The FTC can challenge deceptive or unfair claims about accuracy, safety, bias, privacy, security, data deletion, or whether a human reviews AI outputs. Companies must maintain security appropriate to the sensitivity of their health data. Federal Trade Commission
FTC Health Breach Notification Rule — United States	May require notification to affected individuals, the FTC, and sometimes the media after a breach of identifiable health information. A consumer AI health app may be covered even when its developer is not a HIPAA covered entity. Federal Trade Commission
Children’s Online Privacy Protection Act (COPPA) — United States	Applies to pediatric AI apps, symptom checkers, educational health tools, and connected devices. It affects parental consent, data minimization, notices, retention, and disclosure of children’s information.
Family Educational Rights and Privacy Act (FERPA) — United States	Relevant when AI processes student health records maintained by schools. Such records may be governed by FERPA rather than HIPAA, or by both regimes in different circumstances. Vendors generally need appropriate institutional agreements and limits on redisclosure.
Section 1557 implementing regulations — United States	Can affect AI-supported clinical, administrative, insurance, and patient-access decisions. Organizations should evaluate disparate impact, accessibility, language access, proxy discrimination, and whether patients can obtain meaningful human assistance.
State comprehensive consumer-privacy laws — United States	Laws such as the CCPA/CPRA, Colorado Privacy Act, Connecticut Data Privacy Act, Virginia CDPA, Texas Data Privacy and Security Act, Oregon Consumer Privacy Act, and others may cover health information outside HIPAA. They can create rights to access, delete, correct, opt out, restrict sensitive-data processing, or challenge certain profiling and automated decisions. The US state landscape changes frequently; in 2026, numerous states have comprehensive privacy laws in effect. multistate.us1
California Consumer Privacy Act and California Privacy Rights Act — California	Covers certain health and biometric information that may fall outside HIPAA. AI-related requirements can involve notices, sensitive-personal-information controls, data minimization, risk assessments, automated decision-making disclosures or opt-outs, and restrictions on sharing or selling data.
Washington My Health My Data Act — Washington; applies to qualifying businesses handling consumer health data, often outside traditional healthcare	Requires specific disclosures and, in some circumstances, consent for collecting or sharing consumer health data. It can affect reproductive-health information, inferences, location data, wellness data, prompts, and AI-generated health profiles.
State biometric-privacy laws, especially Illinois BIPA, Texas CUBI, and Washington biometric rules — United States	AI systems using facial recognition, voiceprints, fingerprints, gait, iris scans, or other biometric identifiers may require notice, consent, retention policies, security, and restrictions on disclosure. Some laws create significant private litigation exposure.
State genetic-privacy laws — United States	Can impose consent, disclosure, deletion, security, and sharing restrictions beyond GINA and HIPAA. AI developers using DNA, genomic data, or genetic inferences should evaluate both the source data and model-generated inferences.
False Claims Act and Medicare/Medicaid program rules — United States; apply to claims submitted to federal healthcare programs	Inaccurate AI-supported coding, documentation, risk adjustment, billing, or medical-necessity determinations may lead to repayment obligations, penalties, or liability if errors are knowingly ignored or systems are deliberately manipulated.
State health-data, reproductive-health, and abortion-data laws — United States	May restrict collection, sale, geofencing, subpoenas, disclosure, or use of reproductive and sexual-health information. AI systems must control secondary use, location data, inference generation, and disclosure to third parties.
State medical-practice, telehealth, and professional-licensing laws — United States	AI cannot generally be used to evade licensure, scope-of-practice, informed-consent, supervision, or standard-of-care requirements. Clinicians remain responsible for appropriate review and use of AI recommendations.
State breach-notification and data-security laws — United States	May require notice for incidents involving health, biometric, genetic, or identifying information, even when HIPAA does not apply. AI vendors and providers need incident classification, contractual notice deadlines, forensic procedures, and state-specific response plans.
State unfair or deceptive acts and practices laws — United States	State attorneys general can challenge unsupported claims about AI accuracy, safety, privacy, human oversight, or clinical benefit. Marketing and product documentation should match validated capabilities and known limitations.
Common-law confidentiality, state medical-record laws, and physician-patient privilege — United States; vary by state and apply to healthcare relationships and records	These rules may restrict disclosure or retention beyond HIPAA, establish patient access rights, or protect communications. AI vendors should review state record-retention, confidentiality, consent, and redisclosure rules where patients are treated.
State AI-specific laws and executive requirements — United States; applicability varies by state and sector	Some states regulate high-risk automated decisions, discrimination, biometric AI, deepfakes, insurance decisions, or government use of AI. Healthcare organizations should check the law of each state in which patients, clinicians, or regulated decisions are located.
Federal Common Rule, 45 CFR Part 46, and FDA human-subject protections — United States	AI research using identifiable patient data may require institutional review board review, informed consent or a waiver, privacy safeguards, data-monitoring procedures, and limits on secondary use.
Health Insurance Portability and Accountability Act research provisions — United States	Research teams may need patient authorization, an IRB or privacy-board waiver, a limited-data-set agreement, or properly de-identified data. AI model training is not automatically a permitted research use simply because the data came from a healthcare institution.
Federal Information Security Modernization Act (FISMA), NIST standards, and federal-contract requirements — United States; apply to federal agencies and contractors when incorporated into contracts or applicable systems	AI handling federal health data may need specified security controls, risk management, continuous monitoring, documentation, and incident reporting. NIST frameworks are generally voluntary unless adopted by contract, regulation, or policy, but are commonly used to operationalize AI governance.
Section 508 of the Rehabilitation Act — United States; applies to federal agencies and covered federal technology	Federal healthcare-related AI interfaces, portals, and digital services must be accessible to people with disabilities. Accessibility should be tested for patient-facing chatbots, voice systems, portals, and clinician tools.

Thoughtful AI adoption is less about buying software and more about building a safe operating model. For more healthcare privacy, AI, and digital health implementation guidance, visit the Digital HealthCore Ai+ news and insights blog.

FAQs - Frequently Asked Questions

Can physicians use AI with protected health information?

Yes, but only with proper safeguards. If an AI vendor handles PHI for a covered entity, the vendor usually needs a Business Associate Agreement and must follow HIPAA-related obligations. The practice also needs access controls, security review, and approved workflows.

Does a patient need to consent before a physician uses AI?

The answer depends on the use case, state law, and practice policy. For tools such as ambient documentation, many organizations use clear patient notice and consent or acknowledgment processes. Legal counsel should review the approach.

Can doctors paste patient information into a public AI chatbot?

That is risky and often inappropriate unless the tool has been formally approved for PHI, has the right contractual protections, and meets security requirements. Staff should be trained not to enter PHI into unapproved AI tools.

Who is responsible if AI gives incorrect medical advice?

Physicians and healthcare providers remain responsible for clinical judgment and patient care. AI-generated content should be treated as a draft or a governed support tool unless it has been specifically reviewed, validated, and approved for a defined use.

www.digitalhealthcore.com

Digital HealthCore | Newsroom & Blog

Healthcare+Ai in Focus: The Digital HealthCore Newsroom and blog features articles & case studies that explore Ai, Digital Health Tools, Technologies, & Platforms.